Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | CALCR | P30988 | 5/20 | 0.57 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.57 |
| ▸ | NPY2R | P49146 | 7/20 | 0.57 |
| ▸ | NPY4R | P50391 | 7/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.57 |
| ▸ | NPY1R | P25929 | 5/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.55 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.55 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.55 |
| ▸ | APLNR | P35414 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262247 | 0.91 | C5AR1 (0.62) | F2CALCRRAMP3NMUR2NMUR1 | |
| SCHEMBL29811050 | 0.89 | NPY2R (0.68) | F2CALCRRAMP3NPY2RNPY4R | |
| SCHEMBL29679615 | 0.85 | RAMP3 (0.60) | F2CALCRRAMP3NPY2RNPY4R | |
| SCHEMBL30432035 | 0.85 | NPY2R (0.59) | F2CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29903333 | 0.85 | APLNR (0.61) | F2CALCRRAMP3NPY2RNPY4R | |
| SCHEMBL31148886 | 0.85 | CALCR (0.70) | F2CALCRRAMP3NPY2RNPY4R | |
| SCHEMBL31683361 | 0.85 | CALCR (0.60) | F2CALCRRAMP3NPY2RNPY4R | |
| SCHEMBL26322 | 0.84 | F2 (0.80) | F2CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL26323 | 0.84 | F2 (0.80) | F2CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30432441 | 0.84 | CALCR (0.60) | F2CALCRRAMP3NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |